Bad Blood | Value Investing News

Bad Blood

  • I didn't follow the Theranos story too closely over the years.
  • It was a private company, unprofitable, new-ish and had a ridiculously high valuation, keeping it squarely outside of my investing sweet...
  • [[ Please visit site to read more ]]
Rating: 
No votes yet
Article Link: 
Shared Count: 
0
Value Score: 
-2
Category: